ASH 2017: CLL Combination Therapy News

Description: Can today’s medicines be used together to treat CLL more effectively? CLL expert Dr. Michael Choi of UC San Diego Moores Cancer Center joins Patient Power’s Andrew Schorr at the 2017 American Society of Hematology (ASH) conference. Dr. Choi provides an update on current medicines and discusses promising combination therapies for CLL, including research into combining ibrutinib (Imbruvica) and venetoclax (Venclexta).
Shared By : P2Professional
Posted on : 01/05/18
Added : 2 years ago